CN|EN

Research and development results

Zhejiang Huahai Pharmaceutical Co., Ltd.

2016

We were approved for clinical trials of ambrisentan tablets.

2016

We were approved for clinical trials of topiramate tablets.

2015

We were approved for clinical trials of olanzapine orally disintegrating tablets.

2015

We were approved for clinical trials of pregabalin capsules.

2015

Olanzapine orally disintegrating tablets, topiramate tablets, and pregabalin capsules

2015

we won "Second Prize of National Science and Technology Progress Award" for the research, development, and industrialization of the purification and crystallization technologies for high-end pharmaceutical products.

2014

we won the “First Prize for Scientific & Technological Progress of Tianjin Municipality” for the research, development, and industrialization of the purification and crystallization technologies for high-end pharmaceutical products.

2014

we won "Second Prize of National Science and Technology Progress Award" for the research, development, and industrialization of the green key technologies for anti-hypertension sartan drugs.

2014

we won "Excellence Award for Patents of China" for the method of preparing 2-carbonitrile biphenyl derivatives.

2013

In 2013, we won the “First Prize for Scientific & Technological Progress of Shanghai Municipality” for the research, development, and industrialization of the green key technologies for anti-hypertension sartan drugs.

  • The "R&D and Industrialization Project of Refined Crystallization Technology of High-end Pharmaceutical Products" won the Second Prize of National Science and Technology Progress Award

  • The "Anti-hypertensive Drugs, Losartan Related Green Key Technology Development and Industrialization Project" won the second prize of National Science and Technology Progress Award (2014)

  • In January 2009, the ACEIs (angiotensin converting enzyme inhibitors) related key technology development and industrialization project of the Company won the "Second Prize of National Science and Technology Progress Award"

Copyright 2018 Zhejiang Huahai Pharmaceutical Co., Ltd Zhejiang ICP is No. 05005324. Designed by Wanhu.